GU oncology experts preview top abstracts slated for ASCO 2026
The 2026 ASCO Annual Meeting will run from May 29 to June 2 in Chicago, featuring a dedicated genitourinary (GU) oncology program. Leading clinicians were asked what upcoming abstracts they consider most compelling.
The commentary includes insights from Dr. Chandler Park of Norton Cancer Institute, Dr. Sagar A. Patel of Emory University, Dr. Stephanie A. Berg of Dana‑Farber Cancer Institute and Harvard Medical School, and Dr. Guru P. Sonpavde of AdventHealth Cancer Institute.
Each expert highlighted specific abstracts they are eager to see, citing potential advances in bladder, prostate and kidney cancer treatment and research. They noted the depth of data expected and the relevance to current clinical practice.
This preview offers physicians and investors a glimpse of the scientific trends that may shape GU oncology in the coming year.
This writeup was produced by pharmadog from original reporting by onclive.
Original headline: “GU Cancer Experts Highlight Top Abstracts to Watch During ASCO 2026”
read at onclive ↗
comments(0)
5-min edit window · permanent after that